Summit Global Investments

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1697953 BOUNTIFUL, UT

Position in HRMY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$984,307

+$227,085 QoQ

Shares Held

27,034

0.0% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#145

of 325 holders

Holding Since

Jun 2023

12 quarters on record

Healthcare · as of Jun 30, 2026

Summit Global Investments holds $20,708,446 across 14 Biotechnology names. HRMY ranks #5 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	55,370	$6,276,743
2	REGN	Regeneron Pharmaceuticals, Inc.	7,506	$4,680,291
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,182	$3,567,514
4	BMRN	Biomarin Pharmaceutical Inc	32,667	$1,869,205
5	HRMY	Harmony Biosciences Holdings, Inc. This page	27,034	$984,307
6	KRYS	Krystal Biotech, Inc.	2,167	$805,408
7	PTCT	Ptc Therapeutics, Inc.	7,542	$615,200
8	LGND	Ligand Pharmaceuticals Inc	1,937	$612,266

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$984,307	27,034	0.0%	Shares	Sole	2026-08-03
2026-03-31	$757,222	27,034	+16.6%	Shares	Sole	2026-05-07
2025-12-31	$867,882	23,193	-23.1%	Shares	Sole	2026-02-18
2025-09-30	$830,796	30,145	+45.3%	Shares	Sole	2025-11-03
2025-06-30	$655,415	20,741	-28.9%	Shares	Sole	2025-08-12
2025-03-31	$968,550	29,182	-3.7%	Shares	Sole	2025-04-07
2024-12-31	$1,042,278	30,290	+57.2%	Shares	Sole	2025-02-11
2024-09-30	$770,520	19,263	-4.5%	Shares	Sole	2024-10-31
2024-06-30	$608,347	20,164	+4.2%	Shares	Sole	2024-07-22
2024-03-31	$650,008	19,357	+19.7%	Shares	Sole	2024-04-29
2023-12-31	$522,387	16,173	+64.6%	Shares	Sole	2024-02-06
2023-06-30	$345,812	9,827	—	Shares	Sole	2023-07-19
No filing history on record for this holder in this stock.